Primaquine 26.3 mg

Primaquine 26.3 mg tablets are an antimalarial medication used to treat and prevent malaria. This oral medication is manufactured by Sanofi-Aventis Canada Inc. and is available in a pack of 100 tablets.

Primaquine phosphate is primarily used for the treatment and prevention of malaria. It is often prescribed to eliminate the liver stage parasites that cause malaria, helping to prevent relapses. This medication may also be used in combination with other antimalarials to ensure comprehensive protection against the disease.

Common effects of primaquine phosphate may include gastrointestinal discomfort, such as nausea or stomach pain. Some individuals might experience headaches or dizziness. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

Primaquine should be handled with care, especially by individuals with certain medical conditions like glucose-6-phosphate dehydrogenase (G6PD) deficiency, as it can cause hemolytic anemia. It is important to follow the prescribed dosage and consult a healthcare provider before starting the medication.

Primaquine may interact with certain medications, including some antibiotics and antimalarials. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be avoided while taking primaquine.